Clinical Trial Update: Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers and pilot efficacy biomarkers in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Agglutinin Disease

Snippet

Sponsor: Gliknik Inc. | Conditions: First in Man Study to Evaluate Initial Safety | Phase 1 | Status: RECRUITING